CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 8-K Event Delisting notice
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Delisting notice
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- UPLOAD Other SEC-generated Letter
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
Page 9 of 13 · 258 filings